Morgan Stanley Asia (Singapore) has bought 2.51 lakh shares of Sequent Scientific through open market route. The shares were purchased on an average price of Rs 375 valuing the transaction to Rs 9.42 crore. On the other hand, Satpal Khattar has sold 2.57 lakh shares of the company for an average price of Rs 375.04 through open market route.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
